focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMpac Group Plc Regulatory News (MPAC)

Share Price Information for Mpac Group Plc (MPAC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 477.50
Bid: 470.00
Ask: 485.00
Change: -7.50 (-1.55%)
Spread: 15.00 (3.191%)
Open: 477.50
High: 490.00
Low: 477.50
Prev. Close: 485.00
MPAC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Schedule 1 - Molins Plc

20 May 2014 11:32

RNS Number : 5805H
AIM
20 May 2014
 



 

 

ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH RULE 2 OF THE AIM RULES FOR COMPANIES ("AIM RULES")

COMPANY NAME:

Molins PLC

 

COMPANY REGISTERED OFFICE ADDRESS AND IF DIFFERENT, COMPANY TRADING ADDRESS (INCLUDING POSTCODES) :

Rockingham Drive

Linford Wood East

Milton Keynes

MK14 6LY

 

COUNTRY OF INCORPORATION:

England and Wales

 

COMPANY WEBSITE ADDRESS CONTAINING ALL INFORMATION REQUIRED BY AIM RULE 26:

www.molins.com

 

COMPANY BUSINESS (INCLUDING MAIN COUNTRY OF OPERATION) OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTING POLICY). IF THE ADMISSION IS SOUGHT AS A RESULT OF A REVERSE TAKE-OVER UNDER RULE 14, THIS SHOULD BE STATED:

The principal activities of Molins PLC (the "Company or the "Group") are the design, manufacture and servicing of processing and quality control instrumentation and machinery and the provision of analytical laboratory services for the fast-moving consumer goods, healthcare and pharmaceutical sectors. The Group is organised into three divisions - Scientific Services, Packaging Machinery and Tobacco Machinery.

 

The Group's main country of operation is the UK with its registered office and head office based in Milton Keynes. The Group's overseas locations include facilities and offices in the USA, Canada, Russia, the Netherlands, the Czech Republic, Singapore and Brazil.

 

DETAILS OF SECURITIES TO BE ADMITTED INCLUDING ANY RESTRICTIONS AS TO TRANSFER OF THE SECURITIES (i.e. where known, number and type of shares, nominal value and issue price to which it seeks admission and the number and type to be held as treasury shares):

20,171,540 ordinary shares of 25 pence each.

 

No shares are held in treasury.

 

The shares are freely transferable and have no restrictions placed on them.

 

CAPITAL TO BE RAISED ON ADMISSION (IF APPLICABLE) AND ANTICIPATED MARKET CAPITALISATION ON ADMISSION:

Capital to be raised on admission: n/a

 

Anticipated market capitalisation on admission: £35 million

 

PERCENTAGE OF AIM SECURITIES NOT IN PUBLIC HANDS AT ADMISSION:

30.3%

 

DETAILS OF ANY OTHER EXCHANGE OR TRADING PLATFORM TO WHICH THE AIM COMPANY HAS APPLIED OR AGREED TO HAVE ANY OF ITS SECURITIES (INCLUDING ITS AIM SECURITIES) ADMITTED OR TRADED:

None

 

FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS (underlining the first name by which each is known or including any other name by which each is known):

Avril Palmer-Baunack (Chairman)

Richard (Dick) Clive Hunter (Chief Executive)

David John Cowen (Group Finance Director)

John Lewis Davies (Non-Executive Director)

Philip James Moorhouse (Non-Executive Director)

 

FULL NAMES AND HOLDINGS OF SIGNIFICANT SHAREHOLDERS EXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITAL, BEFORE AND AFTER ADMISSION (underlining the first name by which each is known or including any other name by which each is known):

Shareholders as at before and after admission:

 

Schroder Investment Management Limited

26.08%

Barclays Wealth

6.06%

River & Mercantile Asset Management LLP

5.78%

Charles Stanley

5.06%

Hargreaves Lansdowne Asset Management

4.27%

TD Direct Investing

3.75%

EES Trustees International Limited

3.38%

Mr G V L Oury

3.07%

NAMES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (H) OF THE AIM RULES:

None

 

(i) ANTICIPATED ACCOUNTING REFERENCE DATE

(ii) DATE TO WHICH THE MAIN FINANCIAL INFORMATION IN THE ADMISSION DOCUMENT HAS BEEN PREPARED (this may be represented by unaudited interim financial information)

(iii) DATES BY WHICH IT MUST PUBLISH ITS FIRST THREE REPORTS PURSUANT TO AIM RULES 18 AND 19:

(i) 31 December

(ii) n/a

(iii) 30 September 2014 (interim results for the six month period to 30 June 2014)

30 June 2015 (annual results for the full year to 31 December 2014)

30 September 2015 (interim results for the six month period to 30 June 2015)

 

EXPECTED ADMISSION DATE:

19 June 2014

 

NAME AND ADDRESS OF NOMINATED ADVISER:

Panmure Gordon (UK) Limited

One New Change

London

EC4M 9AF

United Kingdom

 

NAME AND ADDRESS OF BROKER:

Panmure Gordon (UK) Limited

One New Change

London

EC4M 9AF

United Kingdom

 

OTHER THAN IN THE CASE OF A QUOTED APPLICANT, DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIES:

n/a

 

DATE OF NOTIFICATION:

20 May 2014

 

NEW/ UPDATE:

NEW

 

QUOTED APPLICANTS MUST ALSO COMPLETE THE FOLLOWING:

THE NAME OF THE AIM DESIGNATED MARKET UPON WHICH THE APPLICANT'S SECURITIES HAVE BEEN TRADED:

Premium segment of the UKLA Official List / Main Market of the London Stock Exchange

 

THE DATE FROM WHICH THE APPLICANT'S SECURITIES HAVE BEEN SO TRADED:

28 July 1976

 

CONFIRMATION THAT, FOLLOWING DUE AND CAREFUL ENQUIRY, THE APPLICANT HAS ADHERED TO ANY LEGAL AND REGULATORY REQUIREMENTS INVOLVED IN HAVING ITS SECURITIES TRADED UPON SUCH A MARKET OR DETAILS OF WHERE THERE HAS BEEN ANY BREACH:

The Company has adhered to the legal and regulatory requirements of the Official List / Main Market.

 

AN ADDRESS OR WEB-SITE ADDRESS WHERE ANY DOCUMENTS OR ANNOUNCEMENTS WHICH THE APPLICANT HAS MADE PUBLIC OVER THE LAST TWO YEARS (IN CONSEQUENCE OF HAVING ITS SECURITIES SO TRADED) ARE AVAILABLE:

www.molins.com

 

DETAILS OF THE APPLICANT'S STRATEGY FOLLOWING ADMISSION INCLUDING, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTING STRATEGY:

The Company's strategy to achieve its objective of growth across its three divisions can be summarised as follows:

 

-

Increasing the Group's exposure to attractive global industry sectors - nutrition, beverages, healthcare, pharmaceuticals and tobacco

-

Investment in the development of innovative new products and services, the Group's infrastructure and acquisitions in adjacent growth markets

-

Driving operational efficiency through supply chain and customer service excellence, capitalising on opportunities to realise synergies

 

A DESCRIPTION OF ANY SIGNIFICANT CHANGE IN FINANCIAL OR TRADING POSITION OF THE APPLICANT, WHICH HAS OCCURRED SINCE THE END OF THE LAST FINANCIAL PERIOD FOR WHICH AUDITED STATEMENTS HAVE BEEN PUBLISHED:

There has been no significant change in the financial or trading position of Molins PLC since 31 December 2013, being the end of the last financial period for which audited financial statements have been published.

 

A STATEMENT THAT THE DIRECTORS OF THE APPLICANT HAVE NO REASON TO BELIEVE THAT THE WORKING CAPITAL AVAILABLE TO IT OR ITS GROUP WILL BE INSUFFICIENT FOR AT LEAST TWELVE MONTHS FROM THE DATE OF ITS ADMISSION:

The Directors of Molins PLC have no reason to believe that the working capital available to the Company or its Group will be insufficient for at least 12 months from the date of its admission.

 

DETAILS OF ANY LOCK-IN ARRANGEMENTS PURSUANT TO RULE 7 OF THE AIM RULES:

None

 

A BRIEF DESCRIPTION OF THE ARRANGEMENTS FOR SETTLING THE APPLICANT'S SECURITIES:

Settlement will be through the CREST system for dealings in ordinary shares held in uncertificated form. Shares can also be dealt with in certificated form.

 

A WEBSITE ADDRESS DETAILING THE RIGHTS ATTACHING TO THE APPLICANT'S SECURITIES:

www.molins.com

 

INFORMATION EQUIVALENT TO THAT REQUIRED FOR AN ADMISSION DOCUMENT WHICH IS NOT CURRENTLY PUBLIC:

See Appendix 1, available at www.molins.com

 

A WEBSITE ADDRESS OF A PAGE CONTAINING THE APPLICANT'S LATEST ANNUAL REPORT AND ACCOUNTS WHICH MUST HAVE A FINANCIAL YEAR END NOT MORE THEN NINE MONTHS PRIOR TO ADMISSION AND INTERIM RESULTS WHERE APPLICABLE. THE ACCOUNTS MUST BE PREPARED IN ACCORDANCE WITH ACCOUNTING STANDARDS PERMISSIBLE UNDER AIM RULE 19:

www.molins.com/investor-relations/financial-information

 

THE NUMBER OF EACH CLASS OF SECURITIES HELD IN TREASURY:

None

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PAABGGDUBXDBGSG
Date   Source Headline
2nd Sep 20217:00 amRNSHalf Year Results
13th Aug 20217:00 amRNSEquity Development Investor Webinar
27th Jul 20217:00 amRNSChange of Registered Office Address
26th Jul 202112:12 pmRNSMpac new contract
8th Jul 20217:00 amRNSTrading Update
5th May 20215:00 pmRNSResult of AGM
1st Apr 20214:30 pmRNSPosting of 2020 Annual Report and Notice of AGM
1st Apr 20214:27 pmRNSDirectors/PDMRs Dealing
30th Mar 20217:00 amRNSFull Year Results
11th Mar 20213:42 pmRNSEquity Development Investor Webinar Update
10th Mar 202112:02 pmRNSNotice of Results Update
1st Mar 20219:32 amRNSEquity Development Investor Webinar
17th Feb 20218:00 amRNSNotice of Results
7th Jan 20217:00 amRNSFull Year Trading Update
6th Oct 20203:56 pmRNSLaunch of new brand positioning and website
16th Sep 20209:51 amRNSDirector/PDMR Dealing
10th Sep 20203:37 pmRNSDirector/PDMR Dealing
9th Sep 20207:00 amRNSAcquisition of Switchback Group, Inc.
3rd Sep 20207:00 amRNSHalf year results
7th Aug 20208:00 amRNSEquity Development Investor Webinar
8th Jul 20204:41 pmRNSSecond Price Monitoring Extn
8th Jul 20204:36 pmRNSPrice Monitoring Extension
8th Jul 20202:08 pmRNSSecond Price Monitoring Extn
8th Jul 20202:01 pmRNSPrice Monitoring Extension
8th Jul 202011:06 amRNSSecond Price Monitoring Extn
8th Jul 202011:01 amRNSPrice Monitoring Extension
8th Jul 20209:06 amRNSSecond Price Monitoring Extn
8th Jul 20209:00 amRNSPrice Monitoring Extension
8th Jul 20207:00 amRNSOperating update and notice of results
6th May 20203:36 pmRNSResult of AGM
6th May 20207:00 amRNSAGM Statement
3rd Apr 20207:00 amRNSPosting of 2019 Annual Report and Notice of AGM
26th Mar 20207:00 amRNSCOVID-19, trading update and AGM
20th Mar 20202:08 pmRNSSecond Price Monitoring Extn
20th Mar 20202:01 pmRNSPrice Monitoring Extension
16th Mar 202011:06 amRNSSecond Price Monitoring Extn
16th Mar 202011:01 amRNSPrice Monitoring Extension
6th Mar 20207:00 amRNSBoard Change
4th Mar 20207:00 amRNSFull year results
3rd Mar 202012:48 pmRNSHolding(s) in Company
4th Feb 202011:35 amRNSNotice of Results
9th Jan 202011:07 amRNSSecond Price Monitoring Extn
9th Jan 202011:01 amRNSPrice Monitoring Extension
8th Jan 20207:00 amRNSFull year trading update
9th Dec 20197:00 amRNSChange of Adviser
5th Sep 20197:00 amRNSHalf-year results
8th Aug 20192:03 pmRNSNotice of Results
16th Jul 201911:07 amRNSSecond Price Monitoring Extn
16th Jul 201911:01 amRNSPrice Monitoring Extension
16th Jul 20197:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.